Gufic Biosciences Ltd posts net profit of Rs. 20.33 crores in Q3FY23

Gufic Biosciences Limited has reported Standalone financial results for the period ended December 31, 2022.

Financial Results (Q3 FY2023) - QoQ Comparison

The company has reported total income of Rs. 178.2308 crores during the period ended December 31, 2022 as compared to Rs. 175.6537 crores during the period ended September 30, 2022.

The company has posted net profit / (loss) of Rs. 20.3362 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs. 20.2115 crores for the period ended September 30, 2022.

The company has reported EPS of Rs. 2.10 for the period ended December 31, 2022 as compared to Rs. 2.09 for the period ended September 30, 2022.

Financials	Q3 FY2023	Q2 FY2023	% Change
Total Income	₹178.2308 crs	₹175.6537 crs	1.47%
Net Profit	₹20.3362 crs	₹20.2115 crs	0.62%
EPS	₹2.10	₹2.09	0.48%

Financial Results (Q3 FY2023) - YoY Comparison

The company has reported total income of Rs.178.2308 crores during the period ended December 31, 2022 as compared to Rs.173.5957 crores during the period ended December 31, 2021.

The company has posted net profit / (loss) of Rs.20.3362 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs.21.0326 crores for the period ended December 31, 2021.

The company has reported EPS of Rs.2.10 for the period ended December 31, 2022 as compared to Rs.2.17 for the period ended December 31, 2021.

Financials	Q3 FY2023	Q3 FY2022	% Change
Total Income	₹178.2308 crs	₹173.5957 crs	2.67%
Net Profit	₹20.3362 crs	₹21.0326 crs	-3.31%
EPS	₹2.10	₹2.17	-3.23%

Financial Results (9 Months Ended FY2023) - YoY Comparison

The company has reported total income of Rs.519.5355 crores during the 9 Months period ended December 31, 2022 as compared to Rs.620.0260 crores during the 9 Months period ended December 31, 2021.

The company has posted net profit / (loss) of Rs.61.5992 crores for the 9 Months period ended December 31, 2022 as against net profit / (loss) of Rs.75.5759 crores for the 9 Months period ended December 31, 2021.

The company has reported EPS of Rs.6.35 for the 9 Months period ended December 31, 2022 as compared to Rs.7.80 for the 9 Months period ended December 31, 2021.

Financials	9 Months Ended FY2023	9 Months Ended FY2022	% Change
Total Income	₹519.5355 crs	₹620.0260 crs	-16.21%
Net Profit	₹61.5992 crs	₹75.5759 crs	-18.49%
EPS	₹6.35	₹7.80	-18.59%

Shares of Gufic Biosciences Limited was last trading in BSE at Rs. 217.85 as compared to the previous close of Rs. 218.70. The total number of shares traded during the day was 4205 in over 309 trades.

The stock hit an intraday high of Rs. 222.10 and intraday low of 217.15. The net turnover during the day was Rs. 922364.00.

Source : Equity Bulls

Keywords

GuficBiosciences Q3FY23 9MFY23 ResultUpdate